Risk management of insurance operations
|
Page |
|
App1 |
|
Tables |
Page |
|
|
|
|
|
|
|
HSBC's bancassurance model .................. |
233 |
|
|
|
|
|
Overview of insurance products ..................... |
|
|
273 |
|
|
|
Nature and extent of risks .............................. |
|
|
273 |
|
|
|
Insurance risk ................................................ |
|
|
274 |
|
|
|
|
|
|
|
|
|
|
Risk management of insurance operations |
233 |
|
|
|
|
|
Insurance risk ................................................ |
233 |
|
|
|
Analysis of life insurance risk - liabilities to policyholders .......................................................... |
234 |
|
|
|
|
|
Analysis of non-life insurance risk - net written insurance premiums ............................................... |
234 |
|
|
|
|
|
|
|
Balance sheet of insurance manufacturing subsidiaries .................. |
235 |
|
|
|
Balance sheet of insurance manufacturing subsidiaries: |
|
|
|
|
|
|
- by type of contract .................................................. |
236 |
|
|
|
|
|
- by geographical region .......................................... |
237 |
|
|
|
|
|
|
|
Financial risks ............................................ |
238 |
|
275 |
|
Financial assets held by insurance manufacturing subsidiaries ............................................................. |
238 |
Market risk .................................................... |
239 |
|
275 |
|
Liabilities to policyholders .......................................... |
239 |
|
|
|
|
|
Sensitivity of HSBC's insurance manufacturing |
240 |
Credit risk ...................................................... |
240 |
|
277 |
|
Treasury bills, other eligible bills and debt securities in HSBC's insurance manufacturing subsidiaries ........ |
240 |
|
|
|
|
|
Reinsurers' share of liabilities under insurance contracts ................................................................................ |
242 |
Liquidity risk ................................................. |
242 |
|
277 |
|
Expected maturity of insurance contract liabilities ...... |
242 |
|
|
|
|
|
Remaining contractual maturity of investment contract liabilities ................................................................. |
243 |
|
|
|
|
|
|
|
Present value of in-force long-term insurance business ................................. |
243 |
|
|
|
Movements in PVIF and total equity of insurance operations |
244 |
|
|
|
|
|
Key assumptions used in the computation of PVIF for main life insurance operations ................................ |
244 |
|
|
|
|
|
|
|
Economic assumptions ............................... |
244 |
|
|
|
Sensitivity of PVIF to changes in economic assumptions ................................................................................ |
244 |
|
|
|
|
|
|
|
Non-economic assumptions ...................... |
245 |
|
|
|
Sensitivity analysis ...................................................... |
245 |
|
|
|
|
|
|
|
1. Appendix to Risk - policies and practices. |
|
|
|
|
|
|
The majority of the risk in our Insurance business derives from manufacturing activities and can be categorised as insurance risk and financial risk. Insurance risk is the risk, other than financial risk, of loss transferred from the holder of the insurance contract to the issuer (HSBC). Financial risks include market risk, credit risk and liquidity risk.
There were no material changes to our policies and practices for the management of risks arising in the insurance operations, including the risks relating to different life and non-life products, during 2012.
|
A summary of our policies and practices regarding the risk management of insurance operations, and the main contracts we manufacture, are provided in the Appendix to Risk on page 273. |
HSBC's bancassurance model
We operate an integrated bancassurance model which provides wealth and protection insurance products principally for customers with whom we have a banking relationship. Insurance products are sold through all global businesses, predominantly by RBWM and CMB, through our branches and direct channels worldwide.
The insurance contracts we sell largely relate to the underlying needs of our banking customers, which we can identify from our point-of-sale contacts and customer knowledge. The majority of sales are of savings and investment products and term and credit life contracts. By focusing largely on personal and SME lines of business we are able to optimise volumes and diversify individual insurance risks.
Where we have operational scale and risk appetite, mostly in life insurance, these insurance products are manufactured by HSBC subsidiaries. Manufacturing insurance allows us to retain the risks and rewards associated with writing insurance contracts as part of the underwriting profit, investment income and distribution commission are kept within the Group.
Where we do not have the risk appetite or operational scale to be an effective insurance manufacturer, we engage through a handful of leading external insurance companies in order to provide insurance products to our customers through our banking network and direct channels. These arrangements are generally structured with our exclusive strategic partners and earn the Group a combination of commissions, fees and profit-share.
We distribute insurance products in all of our geographical regions. We have core life insurance manufacturing entities, the majority of which are direct subsidiaries of legal banking entities, in seven countries (Argentina, Brazil, Mexico, France, UK, Hong Kong and Singapore). Our life insurance manufacturing entities in the US are held-for-sale at 31 December 2012.
Risk management of insurance operations in 2012
This section provides disclosures on the risks arising from insurance manufacturing operations, including insurance risk and financial risks such as market risk, credit risk and liquidity risk.
Risks in these operations are managed within the insurance entities using methodologies and processes appropriate to the insurance activities, but remain subject to oversight at Group level.
The consolidated Group liquidity and market risk management disclosures exclude insurance operations. The assets of the insurance manufacturing subsidiaries are included within the consolidated Group credit risk disclosures.
Operational and sustainability risks are covered by the Group's overall respective risk management processes and are not included in this section.
Insurance risk
Insurance risk is principally measured in two ways:
· liabilities to policyholders on life insurance contracts; and
· net written insurance premiums for non-life contracts.
The insurance risk profile of our life insurance manufacturing businesses did not change materially during 2012 despite the increase in liabilities to policyholders on these contracts to US$68bn (2011: US$60bn). This growth in liabilities largely resulted from market value gains on underlying financial assets in addition to new business generated during 2012.
The insurance risk profile of our non-life insurance manufacturing businesses changed during the year as net written insurance premiums declined to US$656m (2011: US$993m). This was in line with our strategy to focus on the manufacturing of life insurance products, with non-life manufacturing entities or portfolios in Argentina, Hong Kong, Ireland and Singapore sold during 2012.
A principal risk we continue to face is that, over time, the cost of acquiring and administering a contract, claims and benefits may exceed the aggregate amount of premiums received and investment income. The cost of claims and benefits can be influenced by many factors, including mortality and morbidity experience, lapse and surrender rates and, if the policy has a savings element, the performance of the assets held to support the liabilities.
In respect of financial risks, subsidiaries manufacturing products with guarantees are usually exposed to falls in market interest rates and equity prices to the extent that the market exposure cannot be managed by utilising any discretionary participation (or bonus) features ('DPF') within the policy contracts they issue.
The following tables analyse our insurance risk exposures by geographical region and by type of business. The insurance risk profile and related exposures remained largely consistent with those observed at 31 December 2011.
Analysis of life insurance risk - liabilities to policyholders56
(Audited)
|
Europe |
|
Hong Kong |
|
Rest of Asia- Pacific |
|
NorthAmerica57 |
|
Latin
|
|
Total |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
At 31 December 2012 |
|
|
|
|
|
|
|
|
|
|
|
Life (non-linked) ......................................... |
1,319 |
|
25,615 |
|
1,587 |
|
- |
|
2,163 |
|
30,684 |
Insurance contracts with DPF58 ............... |
353 |
|
23,685 |
|
439 |
|
- |
|
- |
|
24,477 |
Credit life ................................................ |
160 |
|
- |
|
61 |
|
- |
|
- |
|
221 |
Annuities ................................................. |
586 |
|
- |
|
122 |
|
- |
|
1,579 |
|
2,287 |
Term assurance and other long-term |
220 |
|
1,930 |
|
965 |
|
- |
|
584 |
|
3,699 |
|
|
|
|
|
|
|
|
|
|
|
|
Life (linked) ................................................ |
3,249 |
|
3,786 |
|
594 |
|
- |
|
5,427 |
|
13,056 |
|
|
|
|
|
|
|
|
|
|
|
|
Investment contracts with DPF58,59 ............. |
24,370 |
|
- |
|
4 |
|
- |
|
- |
|
24,374 |
|
|
|
|
|
|
|
|
|
|
|
|
Insurance liabilities to policyholders ............ |
28,938 |
|
29,401 |
|
2,185 |
|
- |
|
7,590 |
|
68,114 |
|
|
|
|
|
|
|
|
|
|
|
|
At 31 December 2011 |
|
|
|
|
|
|
|
|
|
|
|
Life (non-linked) ......................................... |
1,163 |
|
21,460 |
|
1,227 |
|
982 |
|
2,094 |
|
26,926 |
Insurance contracts with DPF58 ............... |
335 |
|
20,109 |
|
338 |
|
- |
|
- |
|
20,782 |
Credit life ................................................ |
219 |
|
- |
|
58 |
|
34 |
|
- |
|
311 |
Annuities ................................................. |
517 |
|
- |
|
78 |
|
741 |
|
1,546 |
|
2,882 |
Term assurance and other long-term |
92 |
|
1,351 |
|
753 |
|
207 |
|
548 |
|
2,951 |
|
|
|
|
|
|
|
|
|
|
|
|
Life (linked) ................................................ |
2,508 |
|
3,393 |
|
476 |
|
- |
|
4,833 |
|
11,210 |
|
|
|
|
|
|
|
|
|
|
|
|
Investment contracts with DPF58,59 ............. |
21,477 |
|
- |
|
11 |
|
- |
|
- |
|
21,488 |
|
|
|
|
|
|
|
|
|
|
|
|
Insurance liabilities to policyholders ............ |
25,148 |
|
24,853 |
|
1,714 |
|
982 |
|
6,927 |
|
59,624 |
For footnotes, see page 249.
Our most significant life insurance products are investment contracts with DPF issued in France, insurance contracts with DPF issued in Hong Kong and unit-linked contracts issued in Latin America, Hong Kong and the UK. The decline in life insurance liabilities in North America reflects the classification of this business as held for sale at 31 December 2012.
(Audited)
|
Europe |
|
Hong Kong |
|
Rest of Asia- Pacific |
|
North
|
|
Latin
|
|
Total |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
2012 |
|
|
|
|
|
|
|
|
|
|
|
Accident and health ..................................... |
7 |
|
181 |
|
7 |
|
- |
|
34 |
|
229 |
Motor ......................................................... |
- |
|
14 |
|
20 |
|
- |
|
161 |
|
195 |
Fire and other damage ................................. |
- |
|
20 |
|
15 |
|
24 |
|
20 |
|
79 |
Liability ...................................................... |
- |
|
15 |
|
4 |
|
- |
|
1 |
|
20 |
Credit (non-life) .......................................... |
- |
|
- |
|
- |
|
36 |
|
1 |
|
37 |
Marine, aviation and transport .................... |
- |
|
7 |
|
4 |
|
- |
|
13 |
|
24 |
Other non-life insurance contracts .............. |
5 |
|
33 |
|
1 |
|
3 |
|
30 |
|
72 |
|
|
|
|
|
|
|
|
|
|
|
|
Total net written insurance premiums ......... |
12 |
|
270 |
|
51 |
|
63 |
|
260 |
|
656 |
|
|
|
|
|
|
|
|
|
|
|
|
Net insurance claims incurred and movement |
(5) |
|
(117) |
|
(22) |
|
(24) |
|
(116) |
|
(284) |
|
Europe |
|
Hong Kong |
|
Rest of Asia- Pacific |
|
North
|
|
Latin
|
|
Total |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
2011 |
|
|
|
|
|
|
|
|
|
|
|
Accident and health ..................................... |
23 |
|
186 |
|
8 |
|
- |
|
39 |
|
256 |
Motor ......................................................... |
- |
|
17 |
|
25 |
|
- |
|
328 |
|
370 |
Fire and other damage ................................. |
5 |
|
29 |
|
13 |
|
30 |
|
29 |
|
106 |
Liability ...................................................... |
1 |
|
16 |
|
5 |
|
- |
|
1 |
|
23 |
Credit (non-life) .......................................... |
6 |
|
- |
|
- |
|
48 |
|
1 |
|
55 |
Marine, aviation and transport .................... |
- |
|
10 |
|
3 |
|
- |
|
25 |
|
38 |
Other non-life insurance contracts .............. |
7 |
|
39 |
|
1 |
|
7 |
|
91 |
|
145 |
|
|
|
|
|
|
|
|
|
|
|
|
Total net written insurance premiums ......... |
42 |
|
297 |
|
55 |
|
85 |
|
514 |
|
993 |
|
|
|
|
|
|
|
|
|
|
|
|
Net insurance claims incurred and movement |
56 |
|
(127) |
|
(26) |
|
(22) |
|
(231) |
|
(350) |
|
|
|
|
|
|
|
|
|
|
|
|
2010 |
|
|
|
|
|
|
|
|
|
|
|
Accident and health ..................................... |
78 |
|
174 |
|
8 |
|
3 |
|
37 |
|
300 |
Motor ......................................................... |
- |
|
15 |
|
28 |
|
- |
|
267 |
|
310 |
Fire and other damage ................................. |
38 |
|
29 |
|
11 |
|
16 |
|
22 |
|
116 |
Liability ...................................................... |
- |
|
20 |
|
4 |
|
- |
|
2 |
|
26 |
Credit (non-life) .......................................... |
25 |
|
- |
|
- |
|
53 |
|
2 |
|
80 |
Marine, aviation and transport .................... |
3 |
|
10 |
|
4 |
|
- |
|
18 |
|
35 |
Other non-life insurance contracts .............. |
20 |
|
39 |
|
1 |
|
9 |
|
84 |
|
153 |
|
|
|
|
|
|
|
|
|
|
|
|
Total net written insurance premiums ......... |
164 |
|
287 |
|
56 |
|
81 |
|
432 |
|
1,020 |
|
|
|
|
|
|
|
|
|
|
|
|
Net insurance claims incurred and movement |
(169) |
|
(117) |
|
(25) |
|
(13) |
|
(201) |
|
(525) |
For footnotes, see page 249.
Our motor business was written predominantly in Argentina; this business was sold in May 2012.
Our accident and health and fire and other damage to property contracts was written in all regions but mainly in Hong Kong; this business was sold in November 2012.
Credit non-life insurance, which was historically originated in conjunction with the provision of loans but now in run-off, was concentrated in the US.
Balance sheet of insurance manufacturing subsidiaries
(Audited)
A principal tool used to manage exposures to both financial and insurance risk, in particular for life insurance contracts, is asset and liability matching. In many markets in which we operate it is neither possible nor appropriate to follow a perfect asset and liability matching strategy. For long-dated non‑linked contracts in particular, this results in a duration mismatch between assets and liabilities. We therefore structure portfolios to support projected liabilities from non-linked contracts.
In the absence of insurable events occurring, unit-linked contracts match assets more directly with liabilities. This results in the policyholder bearing the majority of the financial risk exposure.
The tables below show the composition of assets and liabilities by contract and by geographical region and demonstrate that there were sufficient assets to cover the liabilities to policyholders in each case at the end of 2012.
Balance sheet of insurance manufacturing subsidiaries by type of contract
(Audited)
|
Insurance contracts |
|
Investment contracts |
|
|
|
|
||||||||||||
|
With DPF |
|
Unit- |
|
Annu- ities |
|
Term assur- ance61 |
|
Non-life |
With |
With DPF59 |
|
Unit-linked |
|
Other |
|
Otherassets62 |
|
Total |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
At 31 December 2012 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial assets ... |
24,288 |
|
12,619 |
|
1,785 |
|
4,350 |
|
356 |
|
23,620 |
|
8,780 |
|
4,315 |
|
4,692 |
|
84,805 |
- trading assets |
- |
|
- |
|
4 |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
4 |
- financial assets designated at fair value........ |
2,333 |
|
12,440 |
|
571 |
|
756 |
|
196 |
|
6,043 |
|
8,206 |
|
1,486 |
|
987 |
|
33,018 |
- derivatives .... |
40 |
|
4 |
|
- |
|
6 |
|
- |
|
117 |
|
13 |
|
86 |
|
69 |
|
335 |
- financial investments ... |
18,283 |
|
- |
|
932 |
|
3,315 |
|
73 |
|
16,022 |
|
- |
|
1,853 |
|
2,928 |
|
43,406 |
- other financial assets ............. |
3,632 |
|
175 |
|
278 |
|
273 |
|
87 |
|
1,438 |
|
561 |
|
890 |
|
708 |
|
8,042 |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reinsurance assets ........................ |
124 |
|
593 |
|
494 |
|
320 |
|
14 |
|
- |
|
- |
|
- |
|
22 |
|
1,567 |
PVIF63 ................ |
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
4,847 |
|
4,847 |
Other assets and |
448 |
|
7 |
|
34 |
|
110 |
|
11 |
|
754 |
|
24 |
|
28 |
|
2,420 |
|
3,836 |
|
- |
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets ........ |
24,860 |
|
13,219 |
|
2,313 |
|
4,780 |
|
381 |
|
24,374 |
|
8,804 |
|
4,343 |
|
11,981 |
|
95,055 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities under investment contracts: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- designated at fair value ....... |
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
8,691 |
|
3,765 |
|
- |
|
12,456 |
- carried at amortised cost |
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
455 |
|
- |
|
455 |
Liabilities under |
24,477 |
|
13,056 |
|
2,287 |
|
3,920 |
|
81 |
|
24,374 |
|
- |
|
- |
|
- |
|
68,195 |
Deferred tax ....... |
13 |
|
- |
|
13 |
|
12 |
|
1 |
|
- |
|
- |
|
- |
|
1,161 |
|
1,200 |
Other liabilities ... |
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
2,760 |
|
2,760 |
|
- |
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities ... |
24,490 |
|
13,056 |
|
2,300 |
|
3,932 |
|
82 |
|
24,374 |
|
8,691 |
|
4,220 |
|
3,921 |
|
85,066 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity ....... |
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
9,989 |
|
9,989 |
|
- |
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity and |
24,490 |
|
13,056 |
|
2,300 |
|
3,932 |
|
82 |
|
24,374 |
|
8,691 |
|
4,220 |
|
13,910 |
|
95,055 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At 31 December 2011 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial assets ... |
20,520 |
|
10,355 |
|
2,531 |
|
3,398 |
|
1,656 |
|
20,745 |
|
7,843 |
|
4,103 |
|
7,219 |
|
78,370 |
- trading assets |
- |
|
- |
|
3 |
|
- |
|
24 |
|
- |
|
- |
|
- |
|
- |
|
27 |
- financial assets designated at fair value........ |
1,730 |
|
10,101 |
|
426 |
|
594 |
|
206 |
|
5,491 |
|
7,191 |
|
1,515 |
|
1,616 |
|
28,870 |
- derivatives .... |
23 |
|
1 |
|
- |
|
- |
|
- |
|
231 |
|
7 |
|
89 |
|
7 |
|
358 |
- financial investments ... |
15,523 |
|
1 |
|
1,778 |
|
2,540 |
|
791 |
|
13,732 |
|
- |
|
1,913 |
|
4,008 |
|
40,286 |
- other financial assets ............. |
3,244 |
|
252 |
|
324 |
|
264 |
|
635 |
|
1,291 |
|
645 |
|
586 |
|
1,588 |
|
8,829 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reinsurance assets ........................ |
12 |
|
903 |
|
441 |
|
196 |
|
250 |
|
- |
|
- |
|
- |
|
42 |
|
1,844 |
PVIF63 ................ |
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
4,092 |
|
4,092 |
Other assets and |
384 |
|
6 |
|
14 |
|
188 |
|
169 |
|
744 |
|
28 |
|
34 |
|
753 |
|
2,320 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets ........ |
20,916 |
|
11,264 |
|
2,986 |
|
3,782 |
|
2,075 |
|
21,489 |
|
7,871 |
|
4,137 |
|
12,106 |
|
86,626 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities under investment contracts: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- designated at fair value ....... |
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
7,813 |
|
3,586 |
|
- |
|
11,399 |
- carried at amortised cost |
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
435 |
|
- |
|
435 |
Liabilities under |
20,782 |
|
11,210 |
|
2,882 |
|
3,262 |
|
1,635 |
|
21,488 |
|
- |
|
- |
|
- |
|
61,259 |
Deferred tax ....... |
15 |
|
- |
|
21 |
|
6 |
|
1 |
|
- |
|
- |
|
- |
|
931 |
|
974 |
Other liabilities ... |
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
1,930 |
|
1,930 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities ... |
20,797 |
|
11,210 |
|
2,903 |
|
3,268 |
|
1,636 |
|
21,488 |
|
7,813 |
|
4,021 |
|
2,861 |
|
75,997 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity ....... |
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
10,629 |
|
10,629 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity and |
20,797 |
|
11,210 |
|
2,903 |
|
3,268 |
|
1,636 |
|
21,488 |
|
7,813 |
|
4,021 |
|
13,490 |
|
86,626 |
For footnotes, see page 249.
Balance sheet of insurance manufacturing subsidiaries by geographical region56
(Audited)
|
Europe |
|
Hong
|
|
Rest of
|
|
NorthAmerica57 |
|
Latin
|
|
Total |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
At 31 December 2012 |
|
|
|
|
|
|
|
|
|
|
|
Financial assets ............................................ |
37,325 |
|
35,632 |
|
2,594 |
|
- |
|
9,254 |
|
84,805 |
- trading assets ........................................ |
- |
|
- |
|
- |
|
- |
|
4 |
|
4 |
- financial assets designated at fair value .. |
17,590 |
|
7,356 |
|
1,370 |
|
- |
|
6,702 |
|
33,018 |
- derivatives ............................................ |
203 |
|
126 |
|
6 |
|
- |
|
- |
|
335 |
- financial investments ............................ |
17,139 |
|
23,275 |
|
994 |
|
- |
|
1,998 |
|
43,406 |
- other financial assets ............................ |
2,393 |
|
4,875 |
|
224 |
|
- |
|
550 |
|
8,042 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reinsurance assets ....................................... |
809 |
|
715 |
|
8 |
|
- |
|
35 |
|
1,567 |
PVIF63 ......................................................... |
1,140 |
|
2,846 |
|
304 |
|
- |
|
557 |
|
4,847 |
Other assets and investment properties ....... |
849 |
|
983 |
|
230 |
|
1,573 |
|
201 |
|
3,836 |
|
|
|
|
|
|
|
|
|
|
|
|
Total assets ................................................. |
40,123 |
|
40,176 |
|
3,136 |
|
1,573 |
|
10,047 |
|
95,055 |
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities under investment contracts: |
|
|
|
|
|
|
|
|
|
|
|
- designated at fair value .......................... |
7,783 |
|
4,673 |
|
- |
|
- |
|
- |
|
12,456 |
- carried at amortised cost ....................... |
- |
|
- |
|
- |
|
- |
|
455 |
|
455 |
Liabilities under insurance contracts ............ |
28,954 |
|
29,402 |
|
2,200 |
|
- |
|
7,639 |
|
68,195 |
Deferred tax ................................................ |
403 |
|
532 |
|
88 |
|
- |
|
177 |
|
1,200 |
Other liabilities ............................................ |
782 |
|
347 |
|
267 |
|
1,037 |
|
327 |
|
2,760 |
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities ............................................ |
37,922 |
|
34,954 |
|
2,555 |
|
1,037 |
|
8,598 |
|
85,066 |
|
|
|
|
|
|
|
|
|
|
|
|
Total equity ................................................ |
2,201 |
|
5,222 |
|
581 |
|
536 |
|
1,449 |
|
9,989 |
|
|
|
|
|
|
|
|
|
|
|
|
Total equity and liabilities64 ......................... |
40,123 |
|
40,176 |
|
3,136 |
|
1,573 |
|
10,047 |
|
95,055 |
|
|
|
|
|
|
|
|
|
|
|
|
At 31 December 2011 |
|
|
|
|
|
|
|
|
|
|
|
Financial assets ............................................ |
34,163 |
|
30,126 |
|
2,093 |
|
2,414 |
|
9,574 |
|
78,370 |
- trading assets ........................................ |
- |
|
- |
|
- |
|
- |
|
27 |
|
27 |
- financial assets designated at fair value .. |
15,583 |
|
5,875 |
|
1,155 |
|
- |
|
6,257 |
|
28,870 |
- derivatives ............................................ |
244 |
|
114 |
|
- |
|
- |
|
- |
|
358 |
- financial investments ............................ |
15,531 |
|
19,858 |
|
617 |
|
1,846 |
|
2,434 |
|
40,286 |
- other financial assets ............................ |
2,805 |
|
4,279 |
|
321 |
|
568 |
|
856 |
|
8,829 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reinsurance assets ....................................... |
746 |
|
912 |
|
39 |
|
19 |
|
128 |
|
1,844 |
PVIF63 ......................................................... |
1,097 |
|
2,322 |
|
282 |
|
65 |
|
326 |
|
4,092 |
Other assets and investment properties ....... |
909 |
|
946 |
|
31 |
|
24 |
|
410 |
|
2,320 |
|
|
|
|
|
|
|
|
|
|
|
|
Total assets ................................................. |
36,915 |
|
34,306 |
|
2,445 |
|
2,522 |
|
10,438 |
|
86,626 |
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities under investment contracts: |
|
|
|
|
|
|
|
|
|
|
|
- designated at fair value .......................... |
6,961 |
|
4,405 |
|
33 |
|
- |
|
- |
|
11,399 |
- carried at amortised cost ....................... |
- |
|
- |
|
- |
|
- |
|
435 |
|
435 |
Liabilities under insurance contracts ............ |
25,795 |
|
25,160 |
|
1,802 |
|
1,079 |
|
7,423 |
|
61,259 |
Deferred tax ................................................ |
352 |
|
408 |
|
60 |
|
28 |
|
126 |
|
974 |
Other liabilities ............................................ |
1,200 |
|
269 |
|
69 |
|
13 |
|
379 |
|
1,930 |
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities ............................................ |
34,308 |
|
30,242 |
|
1,964 |
|
1,120 |
|
8,363 |
|
75,997 |
|
|
|
|
|
|
|
|
|
|
|
|
Total equity ................................................ |
2,607 |
|
4,064 |
|
481 |
|
1,402 |
|
2,075 |
|
10,629 |
|
|
|
|
|
|
|
|
|
|
|
|
Total equity and liabilities64 ......................... |
36,915 |
|
34,306 |
|
2,445 |
|
2,522 |
|
10,438 |
|
86,626 |
For footnotes, see page 249.
Financial risks
(Audited)
Financial risk exposures can be categorised into:
· Market risk - risks arising from changes in the fair values of financial assets or their future cash flows from fluctuations in variables such as interest rates, foreign exchange rates and equity prices;
· Credit risk - the risk of financial loss following the default of third parties to meet their obligations; and
· Liquidity risk- the risk of not being able to make payments to policyholders as they fall due as there are insufficient assets that can be realised as cash.
Further details on the nature of these financial risks and how they are managed are provided in the Appendix to Risk on page 252.
The following table analyses the assets held in our insurance manufacturing subsidiaries at 31 December 2012 by type of contract, and provides a view of the exposure to financial risk. For linked contracts, which pay benefits to policyholders which are determined by reference to the value of the investments supporting the policies, we typically designate assets at fair value; for non-linked contracts, the classification of the assets is driven by the nature of the underlying contract.
Financial assets held by insurance manufacturing subsidiaries (Audited) |
|||||||||
|
Life linked |
Life non-linked |
|
Non-life |
|
Other |
|
|
|
|
contracts65 |
|
contracts66 |
|
insurance67 |
|
assets62 |
|
Total |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
At 31 December 2012 |
|
|
|
|
|
|
|
|
|
Trading assets |
|
|
|
|
|
|
|
|
|
Debt securities ...................................... |
- |
|
4 |
|
- |
|
- |
|
4 |
|
|
|
- |
|
|
|
|
|
|
Financial assets designated at fair value .... |
20,646 |
|
11,189 |
|
196 |
|
987 |
|
33,018 |
Treasury bills ....................................... |
- |
|
39 |
|
- |
|
- |
|
39 |
Debt securities ...................................... |
8,028 |
|
3,607 |
|
196 |
|
408 |
|
12,239 |
Equity securities ................................... |
12,618 |
|
7,543 |
|
- |
|
579 |
|
20,740 |
|
|
|
|
|
|
|
|
|
|
Financial investments |
|
|
|
|
|
|
|
|
|
Held-to-maturity: debt securities .............. |
- |
|
20,245 |
|
- |
|
1,548 |
|
21,793 |
|
|
|
|
|
|
|
|
|
|
Available-for-sale: ................................... |
- |
|
20,160 |
|
73 |
|
1,380 |
|
21,613 |
- debt securities .................................... |
- |
|
20,160 |
|
66 |
|
1,354 |
|
21,580 |
- equity securities ................................. |
- |
|
- |
|
7 |
|
26 |
|
33 |
|
|
|
|
|
|
|
|
|
|
Derivatives .............................................. |
17 |
|
249 |
|
- |
|
69 |
|
335 |
Other financial assets68 ............................ |
736 |
|
6,511 |
|
87 |
|
708 |
|
8,042 |
|
|
|
|
|
|
|
|
|
|
Total financial assets64 ............................ |
21,399 |
|
58,358 |
|
356 |
|
4,692 |
|
84,805 |
|
|
|
|
|
|
|
|
|
|
At 31 December 2011 |
|
|
|
|
|
|
|
|
|
Trading assets |
|
|
|
|
|
|
|
|
|
Debt securities ...................................... |
- |
|
3 |
|
- |
|
- |
|
3 |
Equity securities ................................... |
- |
|
- |
|
24 |
|
- |
|
24 |
|
|
|
|
|
|
|
|
|
|
Financial assets designated at fair value .... |
17,292 |
|
9,756 |
|
206 |
|
1,616 |
|
28,870 |
Treasury bills ....................................... |
4 |
|
107 |
|
- |
|
- |
|
111 |
Debt securities ...................................... |
6,823 |
|
3,198 |
|
206 |
|
795 |
|
11,022 |
Equity securities ................................... |
10,465 |
|
6,451 |
|
- |
|
821 |
|
17,737 |
|
|
|
|
|
|
|
|
|
|
Financial investments |
|
|
|
|
|
|
|
|
|
Held-to-maturity: debt securities .............. |
- |
|
17,506 |
|
175 |
|
1,300 |
|
18,981 |
|
|
|
|
|
|
|
|
|
|
Available-for-sale: ................................... |
1 |
|
17,980 |
|
616 |
|
2,708 |
|
21,305 |
- other eligible bills .............................. |
- |
|
- |
|
- |
|
50 |
|
50 |
- debt securities .................................... |
- |
|
17,963 |
|
599 |
|
2,520 |
|
21,082 |
- equity securities ................................. |
1 |
|
17 |
|
17 |
|
138 |
|
173 |
|
|
|
|
|
|
|
|
|
|
Derivatives .............................................. |
8 |
|
343 |
|
- |
|
7 |
|
358 |
Other financial assets68 ............................ |
897 |
|
5,709 |
|
635 |
|
1,588 |
|
8,829 |
|
|
|
|
|
|
|
|
|
|
Total financial assets64 ............................ |
18,198 |
|
51,297 |
|
1,656 |
|
7,219 |
|
78,370 |
For footnotes, see page 249.
Approximately 65.6% of financial assets were invested in debt securities at 31 December 2012 (2011: 65.2%) with 24.5% (2011: 22.9%) invested in equity securities.
In life linked insurance, premium income less charges levied is invested in a portfolio of assets. We manage the financial risks of this product on behalf of the policyholders by holding appropriate assets in segregated funds or portfolios to which the liabilities are linked. These assets represented 25.2% (2011: 23.2%) of the total financial assets of our insurance manufacturing subsidiaries at the end of 2012.
The remaining financial risks are managed either solely on behalf of the shareholder, or jointly on behalf of the shareholder and policyholders where DPF exist.
Market risk
(Audited)
Market risk arises when mismatches occur between product liabilities and the investment assets which back them. For example, mismatches between asset and liability yields and maturities give rise to interest rate risk.
Long-term insurance or investment products may incorporate benefits that are guaranteed. Where mismatches exist as a result of current yields falling below guaranteed levels for a prolonged period, the risk that shareholder capital is required to meet liabilities to policyholders increases. The table below shows, in respect of each category of guarantee, the total liabilities to policyholders established for guaranteed products manufactured by our insurance subsidiaries. The table also shows the range of investment returns on the assets supporting these products and the implied investment returns that would enable the business to meet the guarantees.
Immediate annuities, where current investment returns are below guarantees, relate to a closed portfolio in the US which is held for sale at 31 December 2012. Annual return guarantees between 4.5-6%, where current investment returns are below guarantees, is a closed portfolio in Hong Kong. The only other portfolio of contracts identified where current investment returns are below guarantees relate to a closed portfolio in France. This portfolio has reserves of US$495m for which current portfolio yields are 3.25% but investment returns implied by the guarantees are 4.5%.
Liabilities to policyholders69
(Audited)
|
2012 |
|
2011 |
||||||||
|
Amount of reserve |
|
Investment returns implied by guarantee64 |
|
Current yields |
|
Amount of |
|
Investment returns implied by guarantee64 |
|
Current |
|
US$m |
|
% |
|
% |
|
US$m |
|
% |
|
% |
|
|
|
|
|
|
|
|
|
|
|
|
Annuities in payment ................................ |
1,379 |
|
0.0 - 11.7 |
|
4.6 - 20.8 |
|
1,414 |
|
0.0 - 9.6 |
|
4.2 - 25.2 |
Deferred annuities ...................................... |
179 |
|
0.0 - 6.0 |
|
3.3 - 20.4 |
|
175 |
|
0.0 - 6.0 |
|
3.2 - 22.7 |
Immediate annuities70 ................................ |
485 |
|
6.0 - 12.0 |
|
5.4 - 5.5 |
|
538 |
|
6.0 - 12.0 |
|
5.3 - 5.4 |
Annual return ............................................ |
23,878 |
|
0.0 - 2.5 |
|
1.4 - 4.7 |
|
20,465 |
|
0.0 - 2.5 |
|
0.0 - 6.9 |
Annual return ............................................ |
4,315 |
|
2.5 - 4.5 |
|
3.3 - 6.7 |
|
3,849 |
|
2.5 - 4.5 |
|
3.3 - 10.0 |
Annual return ............................................ |
155 |
|
4.5 - 6.0 |
|
4.1 - 4.2 |
|
163 |
|
4.5 - 6.0 |
|
6.4 - 6.5 |
Capital ....................................................... |
18,779 |
|
- |
|
0.0 - 7.2 |
|
17,400 |
|
- |
|
2.3 - 7.8 |
For footnotes, see page 249.
The following table illustrates the effects of selected interest rate, equity price, foreign exchange rate and credit spread scenarios on our profit for the year and total equity of our insurance manufacturing subsidiaries.
Where appropriate, we include the impact of the stress on the PVIF in the results of the sensitivity tests. The relationship between the profit and total equity and the risk factors is non-linear and, therefore, the results disclosed should not be extrapolated to measure sensitivities to different levels of stress. The sensitivities are stated before allowance for management actions which may mitigate the effect of changes in market rates, and for any factors such as policyholder behaviour that may change in response to changes in market risk.
Sensitivity of HSBC's insurance manufacturing subsidiaries to market risk factors
(Audited)
|
2012 |
|
2011 |
||||
|
Effect on |
|
Effect on total equity |
|
Effect on |
|
Effect on total equity |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
|
|
|
|
|
|
|
|
+ 100 basis points parallel shift in yield curves ................... |
125 |
|
(263) |
|
108 |
|
(178) |
- 100 basis points parallel shift in yield curves ................... |
(208) |
|
205 |
|
(115) |
|
191 |
10% increase in equity prices ............................................. |
91 |
|
91 |
|
106 |
|
106 |
10% decrease in equity prices ............................................. |
(92) |
|
(92) |
|
(164) |
|
(164) |
10% increase in US dollar exchange rate |
40 |
|
40 |
|
31 |
|
31 |
10% decrease in US dollar exchange rate |
(40) |
|
(40) |
|
(31) |
|
(31) |
Sensitivity to credit spread increases .................................. |
(18) |
|
(50) |
|
(30) |
|
(75) |
(Audited)
Credit risk can give rise to losses through default and can lead to volatility in our income statement and balance sheet figures through movements in credit spreads, principally on the US$48bn (2011: US$44bn) non‑linked bond portfolio.
As tabulated above, the sensitivity of the net profit after tax of our insurance subsidiaries to the effects of increases in credit spreads has decreased since 2011 due to narrowing of credit spreads experienced in 2012. The balance and related movement are small because about 90% of the debt securities held by our insurance subsidiaries are classified as either held to maturity or available for sale, and consequently any changes in the fair value of these financial investments, absent impairment, would have no effect on the profit after tax. We calculate the sensitivity using simplified assumptions based on a one-day movement in credit spreads over a two-year period. A confidence level of 99%, consistent with our Group VAR, is applied.
Credit quality
(Audited)
The following table presents an analysis of treasury bills, other eligible bills and debt securities within our Insurance business by measures of credit quality. The five credit quality classifications are defined in the Appendix to Risk on page 253. Only assets supporting liabilities under non-linked insurance and investment contracts and shareholders' funds are included in the table as financial risk on assets supporting linked liabilities is predominantly borne by the policyholder. 83.5% (2011: 86.6%) of the assets included in the table are invested in investments rated as strong.
Treasury bills, other eligible bills and debt securities in HSBC's insurance manufacturing subsidiaries
(Audited)
|
Neither past due nor impaired |
|
|
||||||
|
Strong62 |
|
Good |
|
Satisfactory |
|
Sub-standard |
|
Total |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
At 31 December 2012 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supporting liabilities under non-linked |
|
|
|
|
|
|
|
|
|
Trading assets - debt securities .............................. |
1 |
|
- |
|
3 |
|
- |
|
4 |
|
|
|
|
|
|
|
|
|
|
Financial assets designated at fair value .................. |
2,807 |
|
638 |
|
219 |
|
178 |
|
3,842 |
- treasury and other eligible bills ........................ |
39 |
|
- |
|
- |
|
- |
|
39 |
- debt securities ................................................. |
2,768 |
|
638 |
|
219 |
|
178 |
|
3,803 |
|
|
|
|
|
|
|
|
|
|
Financial investments ............................................ |
34,392 |
|
4,265 |
|
1,627 |
|
187 |
|
40,471 |
- debt securities ................................................. |
34,392 |
|
4,265 |
|
1,627 |
|
187 |
|
40,471 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
37,200 |
|
4,903 |
|
1,849 |
|
365 |
|
44,317 |
|
Neither past due nor impaired |
|
|
||||||
|
Strong62 |
|
Good |
|
Satisfactory |
|
Sub-standard |
|
Total |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
Supporting shareholders' funds71 |
|
|
|
|
|
|
|
|
|
Financial assets designated at fair value .................. |
229 |
|
146 |
|
13 |
|
20 |
|
408 |
- debt securities ................................................. |
229 |
|
146 |
|
13 |
|
20 |
|
408 |
|
|
|
|
|
|
|
|
|
|
Financial investments ............................................ |
2,356 |
|
353 |
|
131 |
|
62 |
|
2,902 |
- debt securities ................................................. |
2,356 |
|
353 |
|
131 |
|
62 |
|
2,902 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,585 |
|
499 |
|
144 |
|
82 |
|
3,310 |
|
|
|
|
|
|
|
|
|
|
Total64 |
|
|
|
|
|
|
|
|
|
Trading assets - debt securities .............................. |
1 |
|
- |
|
3 |
|
- |
|
4 |
|
|
|
|
|
|
|
|
|
|
Financial assets designated at fair value .................. |
3,036 |
|
784 |
|
232 |
|
198 |
|
4,250 |
- treasury and other eligible bills ........................ |
39 |
|
- |
|
- |
|
- |
|
39 |
- debt securities ................................................. |
2,997 |
|
784 |
|
232 |
|
198 |
|
4,211 |
|
|
|
|
|
|
|
|
|
|
Financial investments ............................................ |
36,748 |
|
4,618 |
|
1,758 |
|
249 |
|
43,373 |
- debt securities ................................................. |
36,748 |
|
4,618 |
|
1,758 |
|
249 |
|
43,373 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
39,785 |
|
5,402 |
|
1,993 |
|
447 |
|
47,627 |
|
|
|
|
|
|
|
|
|
|
At 31 December 2011 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supporting liabilities under non-linked |
|
|
|
|
|
|
|
|
|
Trading assets - debt securities ............................. |
1 |
|
- |
|
2 |
|
- |
|
3 |
|
|
|
|
|
|
|
|
|
|
Financial assets designated at fair value ................ |
2,851 |
|
168 |
|
349 |
|
143 |
|
3,511 |
- treasury and other eligible bills ....................... |
107 |
|
- |
|
- |
|
- |
|
107 |
- debt securities ................................................ |
2,744 |
|
168 |
|
349 |
|
143 |
|
3,404 |
|
|
|
|
|
|
|
|
|
|
Financial investments .......................................... |
32,062 |
|
2,716 |
|
1,269 |
|
196 |
|
36,243 |
- debt securities ................................................ |
32,062 |
|
2,716 |
|
1,269 |
|
196 |
|
36,243 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34,914 |
|
2,884 |
|
1,620 |
|
339 |
|
39,757 |
|
|
|
|
|
|
|
|
|
|
Supporting shareholders' funds71 |
|
|
|
|
|
|
|
|
|
Financial assets designated at fair value ................ |
341 |
|
348 |
|
61 |
|
45 |
|
795 |
- debt securities ................................................ |
341 |
|
348 |
|
61 |
|
45 |
|
795 |
|
|
|
|
|
|
|
|
|
|
Financial investments .......................................... |
3,198 |
|
560 |
|
83 |
|
29 |
|
3,870 |
- other eligible bills .......................................... |
50 |
|
- |
|
- |
|
- |
|
50 |
- debt securities ................................................ |
3,148 |
|
560 |
|
83 |
|
29 |
|
3,820 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,539 |
|
908 |
|
144 |
|
74 |
|
4,665 |
|
|
|
|
|
|
|
|
|
|
Total64 |
|
|
|
|
|
|
|
|
|
Trading assets - debt securities ............................. |
1 |
|
- |
|
2 |
|
- |
|
3 |
|
|
|
|
|
|
|
|
|
|
Financial assets designated at fair value ................ |
3,192 |
|
516 |
|
410 |
|
188 |
|
4,306 |
- treasury and other eligible bills ....................... |
107 |
|
- |
|
- |
|
- |
|
107 |
- debt securities ................................................ |
3,085 |
|
516 |
|
410 |
|
188 |
|
4,199 |
|
|
|
|
|
|
|
|
|
|
Financial investments .......................................... |
35,260 |
|
3,276 |
|
1,352 |
|
225 |
|
40,113 |
- other eligible bills .......................................... |
50 |
|
- |
|
- |
|
- |
|
50 |
- debt securities ................................................ |
35,210 |
|
3,276 |
|
1,352 |
|
225 |
|
40,063 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38,453 |
|
3,792 |
|
1,764 |
|
413 |
|
44,422 |
For footnotes, see page 249.
Credit risk also arises when assumed insurance risk is ceded to reinsurers. The split of liabilities ceded to reinsurers and outstanding reinsurance recoveries, analysed by credit quality, is shown below. Our exposure to third parties under the reinsurance agreements described in the Appendix to Risk on page 274 is included in this table.
Reinsurers' share of liabilities under insurance contracts
(Audited)
|
Neither past due nor impaired |
|
Past due |
|
|
||||||
|
Strong |
|
Good |
|
|
|
Sub- standard |
|
but not |
|
Total |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
|
|
|
|
|
|
|
|
|
|
|
|
At 31 December 2012 |
|
|
|
|
|
|
|
|
|
|
|
Linked insurance contracts .......................... |
55 |
|
400 |
|
- |
|
- |
|
- |
|
455 |
Non-linked insurance contracts ................... |
936 |
|
4 |
|
6 |
|
- |
|
6 |
|
952 |
|
|
|
|
|
|
|
|
|
|
|
|
Total64 ........................................................ |
991 |
|
404 |
|
6 |
|
- |
|
6 |
|
1,407 |
|
|
|
|
|
|
|
|
|
|
|
|
Reinsurance debtors ..................................... |
19 |
|
133 |
|
- |
|
- |
|
8 |
|
160 |
|
|
|
|
|
|
|
|
|
|
|
|
At 31 December 2011 |
|
|
|
|
|
|
|
|
|
|
|
Linked insurance contracts .......................... |
45 |
|
858 |
|
- |
|
- |
|
- |
|
903 |
Non-linked insurance contracts ................... |
782 |
|
10 |
|
104 |
|
3 |
|
- |
|
899 |
|
|
|
|
|
|
|
|
|
|
|
|
Total64 ........................................................ |
827 |
|
868 |
|
104 |
|
3 |
|
- |
|
1,802 |
|
|
|
|
|
|
|
|
|
|
|
|
Reinsurance debtors ..................................... |
18 |
|
2 |
|
9 |
|
1 |
|
12 |
|
42 |
For footnote, see page 249.
The following tables show the expected undiscounted cash flows for insurance contract liabilities and the remaining contractual maturity of investment contract liabilities at 31 December 2012. A significant proportion of our non-life insurance business is viewed as short-term, with the settlement of liabilities expected to occur within one year of the period of risk. There is a greater spread of expected maturities for the life business where, in a large proportion of cases, the liquidity risk is borne in conjunction with policyholders (wholly borne by the policyholder in the case of unit-linked business).
The profile of the expected maturity of the insurance contracts at 31 December 2012 remained comparable with 2011.
Expected maturity of insurance contract liabilities
(Audited)
|
Expected cash flows (undiscounted) |
||||||||
|
Within 1 year |
|
1-5 years |
|
5-15 years |
|
Over 15 years |
|
Total |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
At 31 December 2012 |
|
|
|
|
|
|
|
|
|
Non-life insurance ................................... |
78 |
|
3 |
|
- |
|
- |
|
81 |
Life insurance (non-linked) ...................... |
4,176 |
|
12,199 |
|
23,420 |
|
27,836 |
|
67,631 |
Life insurance (linked) ............................. |
1,243 |
|
3,761 |
|
10,446 |
|
13,497 |
|
28,947 |
|
|
|
|
|
|
|
|
|
|
Total64 .................................................... |
5,497 |
|
15,963 |
|
33,866 |
|
41,333 |
|
96,659 |
|
|
|
|
|
|
|
|
|
|
At 31 December 2011 |
|
|
|
|
|
|
|
|
|
Non-life insurance ................................... |
742 |
|
704 |
|
176 |
|
13 |
|
1,635 |
Life insurance (non-linked) ...................... |
2,006 |
|
12,243 |
|
21,332 |
|
25,990 |
|
61,571 |
Life insurance (linked) ............................. |
920 |
|
3,262 |
|
9,070 |
|
15,546 |
|
28,798 |
|
|
|
|
|
|
|
|
|
|
Total64 .................................................... |
3,668 |
|
16,209 |
|
30,578 |
|
41,549 |
|
92,004 |
For footnote, see page 249.
Remaining contractual maturity of investment contract liabilities
(Audited)
|
Liabilities under investment contracts by |
||||||
|
Linked investment contracts |
|
Other investment contracts |
|
Investment contracts |
|
Total |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
At 31 December 2012 |
|
|
|
|
|
|
|
Remaining contractual maturity:64 |
|
|
|
|
|
|
|
- due within 1 year ........................................................ |
195 |
|
458 |
|
4 |
|
657 |
- due between 1 and 5 years ........................................... |
675 |
|
- |
|
- |
|
675 |
- due between 5 and 10 years ......................................... |
731 |
|
- |
|
- |
|
731 |
- due after 10 years ....................................................... |
2,061 |
|
- |
|
- |
|
2,061 |
- undated72 .................................................................... |
5,029 |
|
3,762 |
|
24,370 |
|
33,161 |
|
|
|
|
|
|
|
|
|
8,691 |
|
4,220 |
|
24,374 |
|
37,285 |
At 31 December 2011 |
|
|
|
|
|
|
|
Remaining contractual maturity:64 |
|
|
|
|
|
|
|
- due within 1 year ........................................................ |
191 |
|
438 |
|
8 |
|
637 |
- due between 1 and 5 years ........................................... |
595 |
|
- |
|
3 |
|
598 |
- due between 5 and 10 years ......................................... |
548 |
|
- |
|
- |
|
548 |
- due after 10 years ....................................................... |
2,063 |
|
- |
|
- |
|
2,063 |
- undated72 .................................................................... |
4,416 |
|
3,583 |
|
21,477 |
|
29,476 |
|
|
|
|
|
|
|
|
|
7,813 |
|
4,021 |
|
21,488 |
|
33,322 |
For footnotes, see page 249.
Present value of in-force long-term insurance business
(Audited)
Our life insurance business is accounted for using the embedded value approach which, inter alia, provides a risk and valuation framework. The PVIF asset at 31 December 2012 was US$4.8bn (2011: US$4.1bn), representing the present value of the shareholders' interest in the profits expected to emerge from the book of in-force policies at that date.
The PVIF calculation projects expected cash flows, adjusted for a variety of assumptions made by each insurance operation to reflect local market conditions and management's judgement of future trends. The main assumptions relate to economic and non-economic assumptions and policyholder behaviour. Assumptions are subject to uncertainty and can contribute to volatility in the results of the Insurance business.
The key drivers of the movement in the value of the PVIF asset are the expected cash flows from:
· new business adjusted for anticipated maturities and assumptions relating to policyholder behaviour ('Value of new business written during the year');
· unwind of the discount rate less the reversal of expected cash flows for the period ('Expected return');
· changes in non-economic operating assumptions such as mortality or lapse rates ('Change in operating assumptions');
· impacts arising from changes in projected future cash flows associated with operating assumption experience variances compared to those assumed at the start of the period ('Experience variances');
· changes related to future investment returns ('Changes in investment assumptions'); and
· the impact of actual investment experience on future cash flows compared to those assumed at the start of the period ('Investment return variances').
The valuation of the PVIF asset includes explicit risk margins for non-economic risks in the projection assumptions and explicit allowances for financial options and guarantees using stochastic methods. Risk discount rates are set on an active basis with reference to market risk free yields.
The following table shows the movements recorded during the year in respect of total equity and PVIF of insurance operations.
Movements in PVIF and total equity of insurance operations
(Audited)
|
2012 |
|
2011 |
||||
|
PVIF |
|
Totalequity |
|
PVIF |
|
Totalequity |
|
US$m |
|
US$m |
|
US$m |
|
US$m |
|
|
|
|
|
|
|
|
At 1 January ...................................................................... |
4,092 |
|
10,629 |
|
3,440 |
|
9,778 |
|
|
|
|
|
|
|
|
Change in PVIF of long-term insurance business ................. |
737 |
|
737 |
|
726 |
|
726 |
Value of new business written during the year73 ................... |
1,027 |
|
|
|
943 |
|
|
Movements arising from in-force business: |
|
|
|
|
|
|
|
- expected return ........................................................... |
(420) |
|
|
|
(428) |
|
|
- experience variances74 ................................................. |
12 |
|
|
|
1 |
|
|
- changes in operating assumptions ................................ |
(3) |
|
|
|
(222) |
|
|
Investment return variances ............................................... |
(18) |
|
|
|
(103) |
|
|
Changes in investment assumptions ................................... |
78 |
|
|
|
294 |
|
|
Other adjustments .............................................................. |
61 |
|
|
|
241 |
|
|
|
|
|
|
|
|
|
|
Return on net assets ........................................................... |
- |
|
1,232 |
|
- |
|
1,057 |
Capital transactions ........................................................... |
- |
|
(1,525) |
|
- |
|
(500) |
Disposals of subsidiaries/portfolios ..................................... |
- |
|
(382) |
|
- |
|
(96) |
Exchange differences and other .......................................... |
18 |
|
(702) |
|
(74) |
|
(336) |
|
|
|
|
|
|
|
|
At 31 December ................................................................. |
4,847 |
|
9,989 |
|
4,092 |
|
10,629 |
For footnotes, see page 249.
Other adjustments for 2012 included a one-off gain of US$119m for a PVIF asset recognised on linked insurance business in Brazil. For 2011, other adjustments related to the US$243m gain recognised upon refinement of the PVIF calculation.
Key assumptions used in the computation of PVIF for main life insurance operations
(Audited)
|
2012 |
|
2011 |
||||||||
|
UK |
|
Hong Kong |
|
France |
|
UK |
|
Hong Kong |
|
France |
|
% |
|
% |
|
% |
|
% |
|
% |
|
% |
|
|
|
|
|
|
|
|
|
|
|
|
Risk free rate ................................................ |
1.53 |
|
0.60 |
|
2.12 |
|
2.24 |
|
1.47 |
|
2.77 |
Risk discount rate ......................................... |
2.03 |
|
7.46 |
|
4.05 |
|
2.74 |
|
8.00 |
|
5.95 |
Expense inflation ......................................... |
2.84 |
|
3.00 |
|
2.00 |
|
3.45 |
|
3.00 |
|
2.00 |
Economic assumptions
(Audited)
The following table shows the effect on the PVIF of reasonably possible changes in the main economic assumption, risk-free rates, across all insurance manufacturing subsidiaries.
Due to certain characteristics of the contracts, the relationships are non-linear and the results of the sensitivity testing should not be extrapolated to higher levels of stress. The sensitivities shown are before actions that could be taken by management to mitigate effects and before resultant changes in policyholder behaviour.
Sensitivity of PVIF to changes in economic assumptions
(Audited)
|
PVIF at 31 December |
||
|
2012 |
|
2011 |
|
US$m |
|
US$m |
|
|
|
|
+ 100 basis point shift in |
137 |
|
128 |
- 100 basis point shift in |
(191) |
|
(91) |
Non-economic assumptions
(Audited)
We determine the policyholder liabilities for non-life manufacturers by reference to non-economic assumptions including claims costs and expense rates.
Policyholder liabilities and PVIF for life manufacturers are determined by reference to non-economic assumptions including mortality and/or morbidity, lapse rates and expense rates. The table below shows the sensitivity of profit for 2012 and total equity at 31 December 2012 to reasonably possible changes in these non-economic assumptions at that date across all our insurance manufacturing subsidiaries, with comparatives for 2011.
The cost of claims is a risk associated with non-life insurance business. An increase in claims costs would have a negative effect on profit. Sensitivities have significantly decreased since 2011 due to the disposal of the non-life entities or portfolios in Argentina, Hong Kong, Ireland and Singapore during 2012.
Mortality and morbidity risk is typically associated with life insurance contracts. The effect on profit of an increase in mortality or morbidity depends on the type of business being written. Our largest exposures to mortality and morbidity risk exist in Brazil, France, Hong Kong and the US.
Sensitivity to lapse rates depends on the type of contracts being written. For insurance contracts, claims are funded by premiums received and income earned on the investment portfolio supporting the liabilities. For a portfolio of term assurance, an increase in lapse rates typically has a negative effect on profit due to the loss of future premium income on the lapsed policies. However, some contract lapses have a positive effect on profit due to the existence of policy surrender charges. Brazil, France, Hong Kong and the UK are where we are most sensitive to a change in lapse rates.
Expense rate risk is the exposure to a change in expense rates. To the extent that increased expenses cannot be passed on to policyholders, an increase in expense rates will have a negative impact on our profits.
Sensitivity analysis
(Audited)
|
Effect on profit and total |
||||
|
Life |
|
Non-life |
|
Total |
|
US$m |
|
US$m |
|
US$m |
|
|
|
|
|
|
2012 |
|
|
|
|
|
20% increase in claims costs ...................................................... |
- |
|
(12) |
|
(12) |
20% decrease in claims costs ..................................................... |
- |
|
12 |
|
12 |
10% increase in mortality and/or morbidity rates ...................... |
(88) |
|
- |
|
(88) |
10% decrease in mortality and/or morbidity rates ...................... |
92 |
|
- |
|
92 |
50% increase in lapse rates ........................................................ |
(491) |
|
- |
|
(491) |
50% decrease in lapse rates ........................................................ |
842 |
|
- |
|
842 |
10% increase in expense rates ................................................... |
(105) |
|
(1) |
|
(106) |
10% decrease in expense rates ................................................... |
106 |
|
1 |
|
107 |
|
|
|
|
|
|
2011 |
|
|
|
|
|
20% increase in claims costs ...................................................... |
- |
|
(135) |
|
(135) |
20% decrease in claims costs ..................................................... |
- |
|
135 |
|
135 |
10% increase in mortality and/or morbidity rates ...................... |
(100) |
|
- |
|
(100) |
10% decrease in mortality and/or morbidity rates ...................... |
110 |
|
- |
|
110 |
50% increase in lapse rates ........................................................ |
(349) |
|
- |
|
(349) |
50% decrease in lapse rates ........................................................ |
609 |
|
- |
|
609 |
10% increase in expense rates ................................................... |
(89) |
|
(12) |
|
(101) |
10% decrease in expense rates ................................................... |
89 |
|
12 |
|
101 |
Other material risks
|
Page |
|
App1 |
|
Tables |
Page |
|
|
|
|
|
|
|
Reputational risk ....................................... |
246 |
|
278 |
|
|
|
|
|
|
|
|
|
|
Pension risk ................................................ |
246 |
|
278 |
|
|
|
Pension plans in the UK ................................ |
|
|
279 |
|
|
|
The principal plan ......................................... |
246 |
|
|
|
The principal plan - target asset allocation ................. |
247 |
|
|
|
|
|
Benefit payments (US$m) ............................................ |
247 |
Future developments ...................................... |
248 |
|
|
|
|
|
Pension plans in Hong Kong .......................... |
|
|
279 |
|
|
|
The HSBC Group Hong Kong Local Staff Retirement Benefit Scheme ........................ |
248 |
|
|
|
|
|
Pension plans in North America .................... |
|
|
280 |
|
|
|
The HSBC North America (US) Retirement |
249 |
|
|
|
|
|
|
|
|
|
|
|
|
Sustainability risk ..................................... |
249 |
|
280 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1. Appendix to Risk - risk policies and practices. |
|
|
|
|
|
|
Reputational risk
The safeguarding of our reputation is paramount. It is the responsibility of all members of staff, supported by a global risk management structure underpinned by relevant policies and practices, readily available guidance, and regular training.
We have acknowledged, in the context of last year's US Senate Permanent Subcommittee on Investigations, the Deferred Prosecution Agreements with US authorities and the undertakings with the UK FSA, that it was not enough to fix the specific issues that they focused on. Additionally, therefore, we have outlined our implementation of a global strategy to tackle the root causes of these identified deficiencies.
With a new senior leadership team and a new strategy in place since 2011, HSBC has already taken steps to augment the framework to address these issues including making significant changes to strengthen compliance, risk management and culture. These steps, which should also serve, over time, to enhance our reputational risk management, are discussed further on page 278.
Success in detecting and preventing illicit actors' access to the global financial system calls for constant vigilance and HSBC will continue to work in close cooperation with all governments to achieve this. This is integral to the execution of HSBC's strategy, to our core values and to preserving and enhancing our reputation.
Pension risk
(Audited)
We operate a number of pension plans throughout the world. Some are defined benefit plans, of which the largest is the HSBC Bank (UK) Pension Scheme ('the principal plan').
There were no material changes to our policies and procedures for the management of pension risk in 2012.
During 2012, the Group's defined benefit pension plans reduced from a net liability of US$0.2bn to a net asset of US$0.03bn. This was mainly due to growth in the value of the principal plan's assets outstripping the comparable growth in liabilities.
The principal plan
(Audited)
In 2006 the principal plan assets consisted of a strategic portfolio. At the time, HSBC and the trustee of the principal plan agreed to change the investment strategy in order to reduce the investment risk. The target asset allocations for this strategy at that time, as revised in 2011 and at this year end are shown below, demonstrating the ongoing evolution of the strategy. The strategy is to hold the majority of assets in bonds, with the remainder in a more diverse range of investments, and includes a commitment to undertake a programme of swap arrangements (see Note 44 on the Financial Statements) by which the principal plan makes Libor-related interest payments in exchange for the receipt of cash flows which are based on projected future benefit payments to be made from the principal plan.
The principal plan - target asset allocation
2012 |
|
2011 |
|
2006 |
|
|
% |
|
% |
|
% |
|
|
|
|
|
|
Equities ................. |
15.5 |
|
15.5 |
|
15.0 |
Bonds .................... |
60.5 |
|
60.5 |
|
50.0 |
Alternative assets75 .............................. |
9.5 |
|
9.5 |
|
10.0 |
Property ............... |
9.0 |
|
9.0 |
|
10.0 |
Cash ...................... |
5.5 |
|
5.5 |
|
15.0 |
|
|
|
|
|
|
|
100.0 |
|
100.0 |
|
100.0 |
For footnote, see page 249.
As a result of a special contribution to the principal plan in June 2010 of £1,760m (US$2,638m), a cash generating portfolio was established. The portfolio comprised supra-national, agency and government-guaranteed securities, ABSs, corporate subordinated debt and auction rate securities. A further special contribution in December 2011 of £184m (US$286m) added to this portfolio. The contribution was used to purchase ABSs from HSBC at an arm's length value determined by the Scheme's independent third-party advisers. However, these assets may be supplemented with other assets from time to time.
The latest actuarial valuation of the principal plan was made as at 31 December 2011 by C G Singer, Fellow of the Institute of Actuaries, of Towers Watson Limited. At that date, the market value of the HSBC Bank (UK) Pension Scheme's assets was £18.3bn (US$28.3bn) (including assets relating to the defined benefit plan, the defined contribution plan and additional voluntary contributions). The market value of the plan assets represented 100% of the amount expected to be required, on the basis of the assumptions adopted, to provide the benefits accrued to members after allowing for expected future increases in earnings. There was therefore no resulting surplus/deficit. The method adopted for this valuation was the projected unit method.
The expected cash flows from the principal plan were projected by reference to the Retail Price Index ('RPI') swap break-even curve at 31 December 2011. Salary increases were assumed to be 0.5% per annum above RPI and inflationary pension increases, subject to a minimum of 0% and a maximum of 5% (maximum of 3% per annum in respect of service accrued since 1 July 2009), were assumed to be in line with RPI. The projected cash flows were discounted at the Libor swap curve at 31 December 2011 plus a margin for the expected return on the investment strategy of 160bps per annum. The mortality experience of the principal plan's pensioners over the six-year period (2006-2011) was analysed and, on the basis of this analysis, the mortality assumptions were set, based on the SAPS S1 series of tables adjusted to reflect the pensioner experience. Allowance was made for future improvements to mortality rates in line with the Continuous Mortality Investigation core projections with a long run improvement rate set at 2% for males and 1.5% for females. The benefits payable from the defined benefit plan from 2013 are expected to be as shown in the chart below.
Benefit payments (US$m)
As part of the 31 December 2011 valuation, calculations were also carried out as to the amount of assets that might be needed to meet the liabilities if the Scheme was discontinued and the members' benefits bought out with an insurance company (although in practice this may not be possible for a plan of this size) or the Trustee continued to run the plan without the support of HSBC. The amount required under this approach was estimated to be £26.2bn (US$40.6bn) as at 31 December 2011. In arriving at this estimation, a more prudent assumption about future mortality was made than for the assessment of the ongoing position and it was assumed that the Trustee would alter the investment strategy to be an appropriately matched portfolio of UK government bonds. An explicit allowance for expenses was also included.
Based on the latest valuation as at 31 December 2011 and there being no deficit, no Technical Provisions Recovery Plan is required and the schedule of future funding payments agreed after the 2008 actuarial valuation was dissolved.
HSBC and the Trustee have developed a general framework, which, over time, will see the Scheme's asset strategy evolve to be less risky and further aligned to future cash-flows, referred to as the Target Matching Portfolio ('TMP'). Evolution to the TMP can be achieved by asset returns in excess of that assumed and/or additional funding. In February 2013, HSBC agreed to make three general framework contributions of £64m (US$103m) in each of the calendar years 2013, 2014 and 2015.
After the 2008 valuation, HSBC considered that the agreed recovery plan payments, together with investment returns (at an expected level of 240 basis points above the Libor swap curve), would be sufficient to meet the deficit as at 31 December 2008 over the agreed period. HSBC also agreed with the Trustee, that at each subsequent actuarial valuation any shortfall in investment returns relative to this expected level, subject to a maximum of 50 basis points per annum, would be eliminated by payment of equal cash instalments over the remaining years to the end of the recovery plan period.
Although the 2011 triennial valuation disclosed no deficit and therefore no technical provisions recovery plan is required, HSBC and the Trustee have agreed to maintain this investment performance underwriting agreement. The investment performance will be assessed every three years, with an end date of 31 December 2017. Any payments due would only be payable if a Technical Provisions deficit is present at the reference date.
HSBC Bank is also making ongoing contributions to the principal plan in respect of the accrual of benefits of defined benefit section members. Since April 2010, after completion of the 2008 valuation, HSBC has paid contributions at the rate of 34% of pensionable salaries (less member contributions).
Following completion of the 2011 triennial valuation, HSBC will pay contributions at the rate of 43% of pensionable salaries (less member contributions) from 1 April 2013. An additional employer contribution will be paid on or before 30 April 2013 equal to 9% of pensionable salaries, in respect of the period 1 January 2012 to 31 March 2013.
Future developments
(Unaudited)
In January 2013, as part of a wider review of employee benefits, HSBC announced proposals to cease future accrual of service for active members of the Defined Benefit Section with effect from 30 June 2014. Under the proposals, all active members of the Defined Benefit Section will become deferred members from 30 June 2014 (and will become members of the Defined Contribution Section from 1 July 2014).
The valuation of the Scheme's defined benefit obligation is sensitive to changes in actuarial assumptions. The proposed removal of future salary escalation from the pay assumptions is estimated to reduce the defined benefit obligation by approximately US$0.3bn and the proposed change in the underlying inflation assumption for indexation from RPI, for active members, to CPI, for deferred members, by a further US$0.5bn. The proposed cessation of the Scheme to provide ill-health benefits to members, to be covered by insurance policies provided by HSBC under these proposals, is estimated to reduce the defined benefit obligation by approximately US$0.5bn.
The consultation period for these proposals will end, and a final decision is expected to be made, in the second quarter of 2013 at which time a past service credit will be recognised in the income statement.
The future effect of these proposed changes on the income statement is dependent primarily on the level of pension contributions made by HSBC and employees to the Defined Contribution Section, the final outcome of which remains uncertain. In all reasonably likely scenarios, the net effect on earnings over time is not expected to be material.
(Audited)
The scheme mainly invests in bonds with a smaller portion in equities and each investment manager has been assigned an investment mandate with the targeted asset allocation. The ranges of target asset allocations for the portfolio are as follows: Bonds and cash 55-100%, Equity 0-25% and Alternative Investments 0-20%. Alternative Investments refer to high-return and high-risk alternatives, including but not limited to private equity funds, hedge funds, energy, gold, agriculture, commodities and distressed assets.
The latest actuarial valuation of the defined benefit scheme was made at 31 December 2010 by Wing Lui, Fellow of the Society of Actuaries, of Towers Watson Hong Kong Limited. At that valuation date, the market value of the defined benefit scheme's assets was US$1,109m. On an ongoing basis, the defined benefit scheme's assets represented 104% of the actuarial present value of the benefits accrued to members, after allowing for expected future increases in salaries, and the resulting surplus amounted to US$41m. On a wind-up basis, the scheme's assets represented 110% of the members' vested benefits, based on current salaries, and the resulting surplus amounted to US$105m. The attained age method has been adopted for the valuation and the major assumptions used in this valuation were a discount rate of 6% per annum and long-term salary increases of 5% per annum. The recommended employer contribution rate as a percentage of scheme salaries is 14.3% over the period 1 January 2011 to 31 December 2013. No additional special contributions have been agreed.
(Audited)
In 2010, the Investment Committee (the 'Committee') unanimously agreed to transition the Plan's target asset allocation mix to 40% equity securities, 59% fixed income securities and 1% cash over a 24‑month period. In 2011, the Committee decided to accelerate this shift to the 2011 year-end and the target asset allocation mix was maintained during 2012. Should interest rates rise faster than currently projected by the Committee, a further shift to a higher percentage of fixed income securities may be made.
In the third quarter of 2012, it was agreed to cease all future contributions under the cash balance formula and freeze the plan with effect from 1 January 2013. While participants with existing balances continue to receive interest credits until the account is distributed, they no longer accrue benefits beginning in 2013.
The most recent actuarial valuation of the plan to determine compliance with US statutory funding requirements was made at 1 January 2012 by Jennifer Jakubowski, Fellow of the Society of Actuaries, Enrolled Actuary, member of the American Academy of Actuaries, formerly of Mercer. At that date, the market value of the plan's assets was US$3,194m. The assets represented 118% of the benefits accrued to members as valued under the provisions of the Pension Protection Act of 2006 that was effective for the plan year beginning 1 January 2008. The resulting surplus amounted to US$479m. The method employed for this valuation was the traditional unit credit method and the discount rate was determined using a segment rate method as selected by HSBC under the relevant regulations, which resulted in an effective interest rate of 7.13% per annum.
Sustainability risk
(Unaudited)
Assessing the environmental and social impacts of providing finance to our customers is integral to our overall risk management processes.
In 2012, we implemented several changes to our policies and procedures to streamline our management of sustainability risks. This ranged from producing guidelines on how we extend the Equator Principles beyond project finance into corporate loans, to technical fixes in our systems to improve the accuracy of our management information.
|
A summary of our current policies and practices regarding reputational risk, pension risk and sustainability risk is provided in the Appendix to Risk on page 278. |
Footnotes to Risk
Credit risk
1 'Other personal loans and advances' include second lien mortgages and other property-related lending.
2 'Financial' includes loans and advances to banks.
3 The amount of the loan commitments reflects, where relevant, the expected level of take-up of pre-approved loan offers made by mailshots to personal customers. In addition to those amounts, there is a further maximum possible exposure to credit risk of US$28bn (2011: US$171bn), reflecting the full take-up of such irrevocable loan commitments. The take-up of such offers is generally at modest levels.
5 Comprising Rest of Asia-Pacific, Middle East and North Africa, and Latin America.
6 HSBC Finance lending is shown on a management basis and includes loans transferred to HSBC USA Inc. which are managed by HSBC Finance.
7 Property acquired through foreclosure is initially recognised at the lower of the carrying amount of the loan or its fair value less estimated costs to sell ('Initial Foreclosed Property Carrying Amount'). The average loss on sale of foreclosed properties is calculated as cash proceeds less the Initial Foreclosed Properties Carrying Amount divided by the unpaid loan principal balance prior to write-down (excluding any accrued finance income) plus certain other ancillary disbursements that, by law, are reimbursable from the cash proceeds (e.g. real estate tax advances) and were incurred prior to our taking title to the property. This ratio represents the portion of our total loss on foreclosed properties that occurred after we took title to the property.
8 The average total loss on foreclosed properties includes both the loss on sale of the foreclosed property as discussed in footnote 7 and the cumulative write-downs recognised on the loans up to the time we took title to the property.
9 'Other commercial loans and advances' include advances in respect of agriculture, transport, energy and utilities.
10 Impairment allowances are not reported for financial instruments whereby the carrying amount is reduced directly for impairment and not through the use of an allowance account.
11 Impairment is not measured for assets held in trading portfolios or designated at fair value as assets in such portfolios are managed according to movements in fair value, and the fair value movement is taken directly to the income statement. Consequently, we report all such balances under 'Neither past due nor impaired'.
12 'Loans and advances to customers' includes asset-backed securities that have been externally rated as strong (2012: US$2.3bn; 2011: US$3.5bn), good (2012: US$457m; 2011: US$476m), satisfactory (2012: US$390m; 2011: US$428m), sub-standard (2012: US$422m; 2011: US$556m) and impaired (2012: US$259m; 2011: US$229m).
13 Included in this category are loans of US$2.3bn (2011: US$2.9bn) that have been re-aged once and were less than 60 days past due at the point of re-age. These loans are not classified as impaired following re-age due to the overall expectation that these customers will perform on the original contractual terms of their borrowing in the future.
14 'Impaired loans and advances' are those classified as CRR 9, CRR 10, EL 9 or EL 10, retail loans 90 days or more past due, unless individually they have been assessed as not impaired (see page 156, 'Past due but not impaired gross financial instruments') and renegotiated loans and advances meeting the criteria to be disclosed as impaired (see page 162).
15 'Collectively assessed loans and advances' comprise homogeneous groups of loans that are not considered individually significant, and loans subject to individual assessment where no impairment has been identified on an individual basis, but on which a collective impairment allowance has been calculated to reflect losses which have been incurred but not yet identified.
16 'Collectively assessed loans and advances not impaired' are those classified as CRR1 to CRR8 and EL1 to EL8 but excluding retail loans 90 days past due and renegotiated loans and advances meeting the criteria to be disclosed as impaired.
17 'Collectively assessed impairment allowances' are allocated to geographical segments based on the location of the office booking the allowances or provisions. Consequently, the collectively assessed impairment allowances booked in Hong Kong may cover assets booked in branches located outside Hong Kong, principally in Rest of Asia-Pacific, as well as those booked in Hong Kong.
18 Included within 'Exchange and other movements' is US$0.8bn of impairment allowances reclassified to held for sale (2011: US$1.6bn).
19 Net of repo transactions, settlement accounts and stock borrowings.
20 As a percentage of loans and advances to banks and loans and advances to customers, as applicable.
21 'Currency translation' is the effect of translating the results of subsidiaries and associates for the previous year at the average rates of exchange applicable in the current year.
22 Negative numbers are favourable: positive numbers are unfavourable.
23 Equity securities not included.
24 'First lien residential mortgages' include Hong Kong Government Home Ownership Scheme loans of US$3.2bn at 31 December 2012 (2011: US$3.3bn). Where disclosed, earlier comparatives were 2010: US$3.5bn; 2009: US$3.5bn; 2008: US$3.9bn.
25 The impairment allowances on loans and advances to banks in 2012 relate to the geographical regions, Europe, North America, and Middle East and North Africa. (2011: Europe and North America).
26 Carrying amount of the net principal exposure.
27 Total includes holdings of ABSs issued by The Federal Home Loan Mortgage Corporation ('Freddie Mac') and The Federal National Mortgage Association ('Fannie Mae').
28 'Directly held' includes assets held by Solitaire where we provide first loss protection and assets held directly by the Group.
29 'Effect of impairments' represents the reduction or increase in the reserve on initial impairment and subsequent reversal of impairment of the assets.
30 The gross principal is the redemption amount on maturity or, in the case of an amortising instrument, the sum of the future redemption amounts through the residual life of the security.
31 Credit default swap ('CDS') gross protection is the gross principal of the underlying instrument that is protected by CDSs.
32 Net principal exposure is the gross principal amount of assets that are not protected by CDSs. It includes assets that benefit from monoline protection, except where this protection is purchased with a CDS.
33 Net exposure after legal netting and any other relevant credit mitigation prior to deduction of the credit valuation adjustment.
34 Cumulative fair value adjustment recorded against exposures to OTC derivative counterparties to reflect their creditworthiness.
35 Funded exposures represent the loan amount advanced to the customer, less any fair value write-downs, net of fees held on deposit.
36 Unfunded exposures represent the contractually committed loan facility amount not yet drawn down by the customer, less any fair value write-downs, net of fees held on deposit.
Eurozone exposures
37 Our available-for-sale holdings in sovereign and agency debt of Italy and Spain include debt held to support insurance contracts which provide discretionary profit participation to policyholders. For such contracts, unrealised movements in liabilities are recognised in other comprehensive income, following the treatment of the unrealised movements on related available-for-sale assets. To the extent that the movements are matched, no movement in the available-for-sale reserve is recognised. For those available-for-sale debt instruments described above that are not held to support insurance contracts which provide discretionary profit participation to policyholders, the available-for-sale reserves at 31 December 2012 were insignificant.
Liquidity and funding
39 The most favourable metrics are a smaller advances to core funding and larger stressed one-month and three-month coverage ratios.
40 The HSBC UK entity shown comprises three legal entities; HSBC Bank plc (including SPEs consolidated by HSBC Bank plc for Financial Statement purposes, HFC Bank Ltd, and all overseas branches), Marks and Spencer Financial Services Limited and HSBC Trust Company (UK) Limited, managed as a single operating entity, in line with the application of UK liquidity regulation as agreed with the UK FSA.
41 The Hongkong and Shanghai Banking Corporation represents the bank in Hong Kong including all overseas branches. Each branch is monitored and controlled for liquidity and funding risk purposes as a stand-alone operating entity.
42 The HSBC USA principal entity shown represents the HSBC USA Inc consolidated group; predominantly HSBC USA Inc and HSBC Bank USA, NA. The HSBC USA Inc consolidated group is managed as a single operating entity.
43 The total shown for other principal HSBC operating entities represents the combined position of all the other operating entities overseen directly by the Risk Management Meeting of the GMB.
44 Estimated liquidity value represents the expected realisable value of assets prior to management assumed haircuts.
45 The undrawn balance for the five largest committed liquidity facilities provided to customers other than facilities to conduits.
46 The undrawn balance for the total of all committed liquidity facilities provided to the largest market sector, other than facilities to conduits.
47 As a result of the significant level of disposal groups held for sale at 31 December 2012, the financial liabilities of the disposal groups held for sale has been separately shown in the table. For further details of the disposal groups held for sale, refer to Note 30 on the Financial Statements.
Market risk
48 The standard deviation measures the variation of daily revenues about the mean value of those revenues.
49 Revenues within the daily distribution graph include all revenues booked in Global Markets (gross of brokerage fees). The effect of any month-end adjustments, not attributable to a specific daily market move, is spread evenly over the days in the month in question. The 2012 daily distribution of trading revenues excludes the effect of the one-off credit valuation adjustment on derivative assets of US$903m.
50 Trading intent portfolios include positions arising from market-making and position taking.
51 Portfolio diversification is the market risk dispersion effect of holding a portfolio containing different risk types. It represents the reduction in unsystematic market risk that occurs when combining a number of different risk types, for example, interest rate, equity and foreign exchange, together in one portfolio. It is measured as the difference between the sum of the VAR by individual risk type and the combined total VAR. A negative number represents the benefit of portfolio diversification. As the maximum and minimum occur on different days for different risk types, it is not meaningful to calculate a portfolio diversification benefit for these measures.
52 The total VAR is non-additive across risk types due to diversification effects.
53 Investments in private equity are primarily made through managed funds that are subject to limits on the amount of investment. Potential new commitments are subject to risk appraisal to ensure that industry and geographical concentrations remain within acceptable levels for the portfolio as a whole. Regular reviews are performed to substantiate the valuation of the investments within the portfolio.
54 Investments held to facilitate ongoing business include holdings in government-sponsored enterprises and local stock exchanges.
55 Instead of assuming that all interest rates move together, we group our interest rate exposures into currency blocs whose rates are considered likely to move together. See 'Cautionary Statement regarding Forward-Looking Statements' on page 525.
Risk management of insurance operations
56 HSBC has no insurance manufacturing subsidiaries in the Middle East and North Africa.
57 The decline in life insurance liabilities in North America reflects the classification of the majority of this business as held for sale at 31 December 2012. At 31 December 2012, the held-for-sale North American life insurance liabilities by contract type comprised credit life contracts (US$15m), annuities (US$723m) and term assurance and other long-term contracts (US$205m).
58 Insurance contracts and investment contracts with discretionary participation features ('DPF') can give policyholders the contractual right to receive, as a supplement to their guaranteed benefits, additional benefits that may be a significant portion of the total contractual benefits, but whose amount and timing are determined by HSBC. These additional benefits are contractually based on the performance of a specified pool of contracts or assets, or the profit of the company issuing the contracts.
59 Although investment contracts with DPF are financial investments, HSBC continues to account for them as insurance contracts as permitted by IFRS 4.
60 Net written insurance premiums represent gross written premiums less gross written premiums ceded to reinsurers.
61 Term assurance includes credit life insurance.
62 The Other assets column shows shareholder assets as well as assets and liabilities classified as held for sale. The majority of the assets for insurance businesses classified as held for sale are reported as 'Other assets and investment properties' and totalled US$2.0bn at 31 December 2012 (2011: US$0.1bn). Assets classified as held for sale consist primarily of debt securities, the majority of which have a 'strong' credit rating at 31 December 2012. All liabilities for insurance businesses classified as held for sale are reported in 'Other liabilities' and totalled US$1.2bn at 31 December 2012 (2011: US$0.1bn). The majority of these liabilities were life and non-life policyholder liabilities expected to mature after 5 years.
63 Present value of in-force long-term insurance contracts and investment contracts with DPF.
64 Does not include associated insurance companies, SABB Takaful Company and Bao Viet Holdings, or joint venture insurance companies, Hana Life and Canara HSBC Oriental Bank of Commerce Life Insurance Company Limited.
65 Comprise life linked insurance contracts and linked long-term investment contracts.
66 Comprise life non-linked insurance contracts and non-linked long-term investment contracts.
67 Comprise non-life insurance contracts.
68 Comprise mainly loans and advances to banks, cash and intercompany balances with other non-insurance legal entities.
69 The table excludes contracts where the risk is 100% reinsured.
70 The majority of reserves for immediate annuities with guarantees are within insurance businesses that are held for sale at 31 December 2012.
71 Shareholders' funds comprise solvency and unencumbered assets.
72 In most cases, policyholders have the option to terminate their contracts at any time and receive the surrender values of their policies. These may be significantly lower than the amounts shown.
73 Value of net new business during the year is the present value of the projected stream of profits from the business.
74 Experience variances include the effect of the difference between demographic, expense and persistency assumptions used in the previous PVIF calculation and actual experience observed during the year to the extent this impacts profits on future business.
Pension risk
75 In 2011 and 2012, alternative assets included ABSs, MBSs and infrastructure assets. In 2006, alternative assets included loans and infrastructure assets.